Disarm Therapeutics - Ownership and Business Overview

Life ScienceCompany

Disarm Therapeutics Ownership

Who owns Disarm Therapeutics?

Disarm Therapeutics is owned by Eli Lilly. It was acquired on October 15, 2020.

Disarm Therapeutics Business Overview

Where is Disarm Therapeutics headquartered?

Disarm Therapeutics is headquartered in Cambridge, Massachusetts.

What sector is Disarm Therapeutics in?

Disarm Therapeutics is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

Disarm Therapeutics

1 Main Street, 11th Floor,
Cambridge, Massachusetts 02142
United States,
(617) 752-6884
www.disarmtx.com

Disarm Therapeutics is a privately-held biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration. Disarm Therapeutics is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.